Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903876105> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2903876105 endingPage "109" @default.
- W2903876105 startingPage "105" @default.
- W2903876105 abstract "Introduction: Diacerein and oxaceprol are frequently used for the treatment of Grade-I & II osteoarthritis of knees. Diacerein acts by blocking the action of interleukin-1 whereas oxaceprol prevents leukocyte infiltration in the synovial joints. Both the drugs are effective. But there are few comparative studies regarding safety and efficacy of these two drugs. Hence we planned this study. Materials and Methods: An open label randomized comparative study was conducted by the departments of Pharmacology and Orthopedics at Dr RPGMC, Tanda, H.P, after taking permission from the IEC. Patients were diagnosed clinically as per American College of Rheumatology (ACR) guidelines and graded radiologically as Grade I & II osteoarthritis of the knee joint based on Kellgren and Lawrence classification. Then considering exclusion criteria, patients were enrolled after taking written informed consent. 31 and 29 patients were enrolled in diacerein and oxaceprol groups respectively. Tab diacerein 50 mg and oxaceprol 200 mg were prescribed twice daily for three months in respective groups. One patient dropped out in each group, who opted for operative intervention after a few days of enrolment. Efficacy was assessed clinically by WOMAC scale during their follow up at three months. Safety was evaluated clinically considering adverse effects and by complete haemogram & blood biochemistry. Results: In diacerein-group, WOMAC score (mean ± S.D.) improved from 48.77± 18.17 to 29.40 ± 19.94 (p-value = 0.00001) and in oxaceprol group from 42.59 ± 19.49 to 26.58 ± 16.83 (p-value = 0.00001). No adverse effect was reported in any group. Conclusion: Both medicines are almost similar in safety and efficacy. Key words: Diacerein, Oxaceprol, Osteoarthritis of knee." @default.
- W2903876105 created "2018-12-22" @default.
- W2903876105 creator A5025198585 @default.
- W2903876105 creator A5049690619 @default.
- W2903876105 creator A5080538677 @default.
- W2903876105 creator A5090742405 @default.
- W2903876105 date "2020-12-15" @default.
- W2903876105 modified "2023-09-23" @default.
- W2903876105 title "To compare the safety and efficacy of diacerein and oxaceprol in the management of grade I & II osteoarthritis of knee" @default.
- W2903876105 doi "https://doi.org/10.18231/2393-9087.2018.0023" @default.
- W2903876105 hasPublicationYear "2020" @default.
- W2903876105 type Work @default.
- W2903876105 sameAs 2903876105 @default.
- W2903876105 citedByCount "0" @default.
- W2903876105 crossrefType "journal-article" @default.
- W2903876105 hasAuthorship W2903876105A5025198585 @default.
- W2903876105 hasAuthorship W2903876105A5049690619 @default.
- W2903876105 hasAuthorship W2903876105A5080538677 @default.
- W2903876105 hasAuthorship W2903876105A5090742405 @default.
- W2903876105 hasBestOaLocation W29038761051 @default.
- W2903876105 hasConcept C126322002 @default.
- W2903876105 hasConcept C141071460 @default.
- W2903876105 hasConcept C142724271 @default.
- W2903876105 hasConcept C1862650 @default.
- W2903876105 hasConcept C197934379 @default.
- W2903876105 hasConcept C198451711 @default.
- W2903876105 hasConcept C204787440 @default.
- W2903876105 hasConcept C2776164576 @default.
- W2903876105 hasConcept C2779286237 @default.
- W2903876105 hasConcept C2908736133 @default.
- W2903876105 hasConcept C68312169 @default.
- W2903876105 hasConcept C71924100 @default.
- W2903876105 hasConceptScore W2903876105C126322002 @default.
- W2903876105 hasConceptScore W2903876105C141071460 @default.
- W2903876105 hasConceptScore W2903876105C142724271 @default.
- W2903876105 hasConceptScore W2903876105C1862650 @default.
- W2903876105 hasConceptScore W2903876105C197934379 @default.
- W2903876105 hasConceptScore W2903876105C198451711 @default.
- W2903876105 hasConceptScore W2903876105C204787440 @default.
- W2903876105 hasConceptScore W2903876105C2776164576 @default.
- W2903876105 hasConceptScore W2903876105C2779286237 @default.
- W2903876105 hasConceptScore W2903876105C2908736133 @default.
- W2903876105 hasConceptScore W2903876105C68312169 @default.
- W2903876105 hasConceptScore W2903876105C71924100 @default.
- W2903876105 hasIssue "3" @default.
- W2903876105 hasLocation W29038761051 @default.
- W2903876105 hasOpenAccess W2903876105 @default.
- W2903876105 hasPrimaryLocation W29038761051 @default.
- W2903876105 hasRelatedWork W2045407791 @default.
- W2903876105 hasRelatedWork W2095038990 @default.
- W2903876105 hasRelatedWork W2145608536 @default.
- W2903876105 hasRelatedWork W2179161202 @default.
- W2903876105 hasRelatedWork W2314638994 @default.
- W2903876105 hasRelatedWork W2743347779 @default.
- W2903876105 hasRelatedWork W2867000880 @default.
- W2903876105 hasRelatedWork W2952982693 @default.
- W2903876105 hasRelatedWork W4293261697 @default.
- W2903876105 hasRelatedWork W4319313185 @default.
- W2903876105 hasVolume "5" @default.
- W2903876105 isParatext "false" @default.
- W2903876105 isRetracted "false" @default.
- W2903876105 magId "2903876105" @default.
- W2903876105 workType "article" @default.